本頁面由Tiger Trade Technology Pte. Ltd.提供服務

神經分泌生物科學

128.41
-3.0300-2.31%
盤後128.40-0.0100-0.01%19:45 EDT
成交量:103.04萬
成交額:1.33億
市值:128.88億
市盈率:27.50
高:131.71
開:131.00
低:127.76
收:131.44
52周最高:160.18
52周最低:97.30
股本:1.00億
流通股本:9,800.26萬
量比:1.04
換手率:1.05%
股息:- -
股息率:- -
每股收益(TTM):4.67
每股收益(LYR):4.67
淨資產收益率:16.38%
總資產收益率:9.53%
市淨率:3.96
市盈率(LYR):27.50

資料載入中...

2021/04/16

重要事件披露

8-K - Current report
2021/04/12

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/04/12

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/16

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/16

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/11

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/10

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/08

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/05

年度報告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2021/02/04

重要事件披露

8-K - Current report
2021/02/02

重要事件披露

8-K - Current report
2021/01/29

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/01/08

重要事件披露

8-K - Current report
2020/11/24

重要事件披露

8-K - Current report
2020/11/19

重要事件披露

8-K - Current report
2020/11/09

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2020/11/09

重要事件披露

8-K - Current report
2020/09/10

重要事件披露

8-K - Current report
2020/08/28

重要事件披露

8-K - Current report
2020/08/03

員工持股計劃

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments